Infants Clinical Trial - Effect of Consumption of a Milk Product Designed

Status Not yet recruiting

Clinical Trial Summary

Vulnerable populations, who have deficient diets, may produce human milk (HML) that is not adequate in all nutrients and this will have consequences on the growth and development of the child. In 2021 at IDIP, a specific milk product for pregnant and lactating women Super Mil Mamá ( SMM, whole milk powder fortified with multiple vitamins, minerals and DHA ) has been designed and developed as part of a key strategy to incorporate in public policies for the first 1000 days of life. However, the potential benefits of this product have not yet been evaluated at the population level. The main objective is to evaluate the effect of the consumption of a milk product (SMM) designed for lactating women on the composition of human milk and the nutritional status of iron and DHA in infant red blood cells in a vulnerable population through a randomized, triple-blind, controlled clinical trial. Specific objectives To compare the concentrations of DHA, Vitamins A, E, and D, Iron, Iodine, Zinc and Calcium in human milk before and after dietary supplementation with SMM. To compare the concentrations of DHA, Vitamins A, E, D and Zinc in blood and the nutritional status of maternal iron before and after dietary supplementation with SMM. To analyze the relationship between micronutrients measured in maternal blood and human milk after dietary supplementation with SMM. To compare the concentrations of micronutrients measured in blood and human milk in women who received SMM and those who received commercial milk (CM) at the end of supplementation. To compare the iron nutritional status and DHA content in red blood cells of infants of mothers who consumed SMM or LC. To evaluate the relationship between the concentration of micronutrients in human milk and infant growth during the first six months of life.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Infants

Clinical Trial Details

NCT number	NCT06319079
Study type	Interventional
Source	Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri
Contact	Maria Florencia Andreoli, PhD
Phone	+542214177324
Email	mfandreoli@gmail.com
Status	Not yet recruiting
Phase	N/A
Start date	March 2024
Completion date	July 2027

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05492253` - First Complementary Foods and the Infant Gastrointestinal Microbiota	N/A
Withdrawn	`NCT01953562` - Positioning and the Spontaneous Breathing Test in Neonates	N/A
Completed	`NCT03716882` - Acoustic Structures Crying of Infants From 1 to 4 Months and Their Signification
Recruiting	`NCT06353841` - Effect of Therapeutic Touch on Functional Constipation in Infants and Young Children	N/A
Recruiting	`NCT05705258` - A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)
Completed	`NCT02119104` - Prevenar (13v) Infant Drug Use Investigation	N/A
Recruiting	`NCT06318858` - Daily and Weekly Iron Supplementation in Infants	N/A
Not yet recruiting	`NCT03047876` - Brain Vascular Reactivity to Hypothermic Circulatory Arrest With Antegrade Cerebral Perfusion During Aortic Arch Surgery
Withdrawn	`NCT05266677` - DHA Proof-of-Concept Study in Infants and Toddlers	N/A
Recruiting	`NCT05940688` - Providing an Optimized and emPowered Pregnancy for You (PᵌOPPY) Feasibility Study	N/A
Not yet recruiting	`NCT06127914` - Learning Early Infant Feeding Cues	N/A
Completed	`NCT03327415` - Nutri-Bébé 2013 Survey on Food Consumption of Infants and Young Children	N/A
Completed	`NCT04598841` - Nutrition Support for Hirschsprung Disease	N/A
Completed	`NCT01664234` - Oxygen Insuflation and ArterialDesaturation During Tracheal Intubation in Children	N/A
Terminated	`NCT02069522` - Healthy Term Infants Fed Milk-Based Formulas	N/A
Completed	`NCT04218929` - Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants	N/A
Recruiting	`NCT01575184` - Effect of Shoulder Traction on Size and Relative Position of Internal Jugular Vein to Carotid Artery	N/A
Not yet recruiting	`NCT05994417` - Beyond Race: Objectively Assessed Skin Color and Its Association With Pulse Oximeter Bias in Critically Ill Infants

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effect of Consumption of a Milk Product Designed for Lactating Women on Human Milk Composition

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms